Name | Number of supported studies | Average coverage | |
---|---|---|---|
basal cell | 18 studies | 36% ± 18% | |
epithelial cell | 8 studies | 37% ± 17% | |
secretory cell | 7 studies | 38% ± 13% | |
ciliated cell | 6 studies | 30% ± 10% | |
mesothelial cell | 6 studies | 39% ± 10% | |
hepatocyte | 5 studies | 50% ± 25% | |
keratinocyte | 4 studies | 55% ± 20% | |
hillock cell | 3 studies | 36% ± 7% | |
squamous epithelial cell | 3 studies | 35% ± 24% | |
cholangiocyte | 3 studies | 38% ± 14% | |
club cell | 3 studies | 22% ± 9% | |
pancreatic ductal cell | 3 studies | 72% ± 12% | |
parietal epithelial cell | 3 studies | 37% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
skin | 4 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 11112.53 | 226 / 226 | 97% | 276.37 | 393 / 406 |
pancreas | 84% | 3097.63 | 275 / 328 | 88% | 169.47 | 156 / 178 |
uterus | 84% | 7777.42 | 142 / 170 | 73% | 353.58 | 333 / 459 |
esophagus | 39% | 2253.24 | 563 / 1445 | 84% | 256.57 | 154 / 183 |
adrenal gland | 96% | 7957.71 | 248 / 258 | 17% | 24.22 | 40 / 230 |
bladder | 33% | 1913.10 | 7 / 21 | 78% | 209.95 | 393 / 504 |
thymus | 22% | 648.91 | 144 / 653 | 82% | 360.74 | 497 / 605 |
kidney | 43% | 1367.63 | 38 / 89 | 56% | 100.35 | 505 / 901 |
lung | 23% | 677.85 | 134 / 578 | 73% | 326.83 | 838 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 96% | 577.18 | 43 / 45 |
skin | 72% | 32045.15 | 1308 / 1809 | 21% | 26.07 | 98 / 472 |
ovary | 23% | 730.94 | 42 / 180 | 68% | 109.75 | 292 / 430 |
prostate | 56% | 2138.13 | 136 / 245 | 31% | 23.09 | 156 / 502 |
intestine | 0% | 1.42 | 1 / 966 | 74% | 88.87 | 391 / 527 |
stomach | 0% | 16.60 | 1 / 359 | 68% | 88.63 | 194 / 286 |
breast | 25% | 714.38 | 116 / 459 | 18% | 25.32 | 204 / 1118 |
adipose | 37% | 3240.89 | 448 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 3.75 | 1 / 29 |
heart | 3% | 82.41 | 27 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 75.96 | 34 / 1335 | 0% | 0 | 0 / 0 |
spleen | 1% | 18.87 | 2 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 14.93 | 5 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 3.44 | 4 / 2642 | 0% | 0.09 | 1 / 705 |
peripheral blood | 0% | 4.46 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060054 | Biological process | positive regulation of epithelial cell proliferation involved in wound healing |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0070673 | Biological process | response to interleukin-18 |
GO_0007155 | Biological process | cell adhesion |
GO_1903348 | Biological process | positive regulation of bicellular tight junction assembly |
GO_0045471 | Biological process | response to ethanol |
GO_0034331 | Biological process | cell junction maintenance |
GO_0008065 | Biological process | establishment of blood-nerve barrier |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0016338 | Biological process | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO_0071548 | Biological process | response to dexamethasone |
GO_0051259 | Biological process | protein complex oligomerization |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_1903545 | Biological process | cellular response to butyrate |
GO_0097421 | Biological process | liver regeneration |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0061772 | Biological process | xenobiotic transport across blood-nerve barrier |
GO_0090557 | Biological process | establishment of endothelial intestinal barrier |
GO_0009636 | Biological process | response to toxic substance |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0071284 | Biological process | cellular response to lead ion |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0070160 | Cellular component | tight junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0005198 | Molecular function | structural molecule activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CLDN1 |
Protein name | Claudin Claudin-1 (Senescence-associated epithelial membrane protein) |
Synonyms | CLD1 hCG_17574 SEMP1 UNQ481/PRO944 |
Description | FUNCTION: Claudins function as major constituents of the tight junction complexes that regulate the permeability of epithelia. While some claudin family members play essential roles in the formation of impermeable barriers, others mediate the permeability to ions and small molecules. Often, several claudin family members are coexpressed and interact with each other, and this determines the overall permeability. CLDN1 is required to prevent the paracellular diffusion of small molecules through tight junctions in the epidermis and is required for the normal barrier function of the skin. Required for normal water homeostasis and to prevent excessive water loss through the skin, probably via an indirect effect on the expression levels of other proteins, since CLDN1 itself seems to be dispensable for water barrier formation in keratinocyte tight junctions . .; FUNCTION: (Microbial infection) Acts as a co-receptor for hepatitis C virus (HCV) in hepatocytes . Associates with CD81 and the CLDN1-CD81 receptor complex is essential for HCV entry into host cell . Acts as a receptor for dengue virus . . FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. . |
Accessions | ENST00000295522.4 O95832 A5JSJ9 |